Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
18.37
-0.40 (-2.13%)
At close: Oct 8, 2025, 4:00 PM EDT
19.22
+0.85 (4.63%)
After-hours: Oct 8, 2025, 5:30 PM EDT

Neuphoria Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
4313----
Upgrade
Enterprise Value
29-4----
Upgrade
Last Close Price
18.377.10----
Upgrade
PS Ratio
1.910.85----
Upgrade
PB Ratio
1.910.70----
Upgrade
P/TBV Ratio
7.792.40----
Upgrade
P/FCF Ratio
560.79172.83----
Upgrade
P/OCF Ratio
560.79172.83----
Upgrade
Debt / Equity Ratio
0.010.010.020.020.010.02
Upgrade
Debt / FCF Ratio
1.931.93----
Upgrade
Asset Turnover
0.560.56--0.100.02
Upgrade
Quick Ratio
3.373.373.334.5812.0212.55
Upgrade
Current Ratio
3.563.563.454.8712.4613.10
Upgrade
Return on Equity (ROE)
-2.03%-2.03%-78.44%-71.40%-41.64%-28.86%
Upgrade
Return on Assets (ROA)
-1.84%-1.84%-39.58%-37.41%-18.40%-14.48%
Upgrade
Return on Capital (ROIC)
-2.81%-2.81%-55.44%-44.40%-20.74%-17.50%
Upgrade
Earnings Yield
-0.85%-2.77%----
Upgrade
FCF Yield
0.18%0.58%----
Upgrade
Buyback Yield / Dilution
-95.06%-95.06%99.94%-8.53%-73.52%-43.14%
Upgrade
Updated Sep 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q